Patricia M. Whitaker-azmitia - Publications

Affiliations: 
Psychology Stony Brook University, Stony Brook, NY, United States 

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Lee AS, Azmitia EC, Whitaker-Azmitia PM. Developmental Microglial Priming in Postmortem Autism Spectrum Disorder Temporal Cortex. Brain, Behavior, and Immunity. PMID 28159644 DOI: 10.1016/J.Bbi.2017.01.019  0.312
2015 Azmitia EC, Saccomano ZT, Alzoobaee MF, Boldrini M, Whitaker-Azmitia PM. Persistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum Journal of Autism and Developmental Disorders. 1-12. DOI: 10.1007/S10803-015-2672-6  0.337
2012 Muneoka K, Funahashi H, Ogawa T, Whitaker-Azmitia PM, Shioda S. Shared features of S100B immunohistochemistry and cytochrome oxidase histochemistry in the ventroposterior thalamus and lateral habenula in neonatal rats. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 30: 499-505. PMID 22627026 DOI: 10.1016/J.Ijdevneu.2012.05.003  0.403
2011 Azmitia EC, Singh JS, Whitaker-Azmitia PM. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology. 60: 1347-54. PMID 21329710 DOI: 10.1016/J.Neuropharm.2011.02.002  0.362
2010 Shapiro LA, Bialowas-McGoey LA, Whitaker-Azmitia PM. Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer's Disease: Studies in an S100B Overexpressing Mouse Model. Cardiovascular Psychiatry and Neurology. 2010. PMID 20827311 DOI: 10.1155/2010/153657  0.562
2010 Whitaker-Azmitia PM. Serotonin and Development Handbook of Behavioral Neuroscience. 21: 309-323. DOI: 10.1016/S1569-7339(10)70086-2  0.395
2008 McNamara IM, Borella AW, Bialowas LA, Whitaker-Azmitia PM. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Research. 1189: 203-14. PMID 18062943 DOI: 10.1016/J.Brainres.2007.10.063  0.388
2007 Shapiro LA, Ng KL, Kinyamu R, Whitaker-Azmitia P, Geisert EE, Blurton-Jones M, Zhou QY, Ribak CE. Origin, migration and fate of newly generated neurons in the adult rodent piriform cortex. Brain Structure & Function. 212: 133-48. PMID 17764016 DOI: 10.1007/S00429-007-0151-3  0.629
2005 Whitaker-Azmitia PM. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 23: 75-83. PMID 15730889 DOI: 10.1016/j.ijdevneu.2004.07.022  0.33
2004 Shapiro LA, Whitaker-Azmitia PM. Expression levels of cytoskeletal proteins indicate pathological aging of S100B transgenic mice: an immunohistochemical study of MAP-2, drebrin and GAP-43. Brain Research. 1019: 39-46. PMID 15306236 DOI: 10.1016/j.brainres.2004.05.100  0.565
2004 Shapiro LA, Marks A, Whitaker-Azmitia PM. Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome. Brain Research. 1010: 17-21. PMID 15126113 DOI: 10.1016/J.Brainres.2003.12.057  0.588
2003 Muneoka KT, Borella A, Whitaker-Azmitia PM. Transient expression of S-100beta immunostaining in developing thalamus and somatosensory cortex of rat. Brain Research. Developmental Brain Research. 142: 101-4. PMID 12694948 DOI: 10.1016/S0165-3806(03)00012-9  0.321
2002 Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, Whitaker-Azmitia PM. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiology & Behavior. 75: 403-10. PMID 11897268 DOI: 10.1016/S0031-9384(01)00673-4  0.579
2001 Whitaker-Azmitia PM. Serotonin and brain development: Role in human developmental diseases Brain Research Bulletin. 56: 479-485. PMID 11750793 DOI: 10.1016/S0361-9230(01)00615-3  0.383
2000 Lawston J, Borella A, Robinson JK, Whitaker-Azmitia PM. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2 Brain Research. 877: 407-410. PMID 10986361 DOI: 10.1016/S0006-8993(00)02739-6  0.327
1999 Whitaker-Azmitia PM. The discovery of serotonin and its role in neuroscience Neuropsychopharmacology. 21: 2S-8S. PMID 10432482 DOI: 10.1016/S0893-133X(99)00031-7  0.308
1998 Whitaker-Azmitia PM. Role of the Neurotrophic Properties of Serotonin in the Delay of Brain Maturation Induced by Cocaine(a). Annals of the New York Academy of Sciences. 846: 158-164. PMID 29087559 DOI: 10.1111/J.1749-6632.1998.Tb09734.X  0.318
1997 Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits Brain Research. 760: 68-73. PMID 9237519 DOI: 10.1016/S0006-8993(97)00297-7  0.387
1997 Borella A, Bindra M, Whitaker-Azmitia PM. Role of the 5-HT(1A) receptor in development of the neonatal rat brain: Preliminary behavioral studies Neuropharmacology. 36: 445-450. PMID 9225268 DOI: 10.1016/S0028-3908(97)00056-7  0.424
1996 Ueda S, Aikawa M, Kawata M, Naruse I, Whitaker-Azmitia PM, Azmitia EC. Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). III. Transplantation study. Brain Research. 738: 15-23. PMID 8949922 DOI: 10.1016/0006-8993(96)00758-5  0.321
1996 Nishi M, Whitaker-Azmitia PM, Azmitia EC. Enhanced synaptophysin immunoreactivity in rat hippocampal culture by 5-HT 1A agonist, S100b, and corticosteroid receptor agonists. Synapse (New York, N.Y.). 23: 1-9. PMID 8723130 DOI: 10.1002/(Sici)1098-2396(199605)23:1<1::Aid-Syn1>3.0.Co;2-E  0.311
1995 Whitaker-Azmitia PM, Borella A, Raio N. Serotonin depletion in the adult rat causes loss of the dendritic marker MAP-2. A new animal model of schizophrenia? Neuropsychopharmacology. 12: 269-272. PMID 7612161 DOI: 10.1016/0893-133X(94)00081-A  0.39
1994 Ueda S, Hou XP, Whitaker-Azmitia PM, Azmitia EC. Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). II. Co-cultures study. Brain Research. 633: 284-8. PMID 8137163 DOI: 10.1016/0006-8993(94)91550-4  0.399
1994 Kramer K, Azmitia EC, Whitaker-Azmitia PM. In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Brain Research. Developmental Brain Research. 78: 142-6. PMID 7911745 DOI: 10.1016/0165-3806(94)90019-1  0.324
1994 Whitaker-Azmitia PM, Zhang X, Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: Preliminary behavioral and neurochemical studies Neuropsychopharmacology. 11: 125-132. PMID 7840864 DOI: 10.1038/Npp.1994.42  0.414
1994 Ueda S, Gu XF, Whitaker-Azmitia PM, Naruse I, Azmitia EC. Neuro-glial neurotrophic interaction in the S-100 beta retarded mutant mouse (Polydactyly Nagoya). I. Immunocytochemical and neurochemical studies. Brain Research. 633: 275-83. PMID 7511035 DOI: 10.1016/0006-8993(94)91549-0  0.374
1994 Whitaker-Azmitia PM. The 5-HT1a Receptor in Development in Adult Brain: Modulation of Brain Function Neuropsychopharmacology. 11: 262-262. DOI: 10.1038/Sj.Npp.1380125  0.406
1993 Whitaker-Azmitia PM, Clarke C, Azmitia EC. Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse (New York, N.Y.). 14: 201-5. PMID 8211706 DOI: 10.1002/Syn.890140303  0.372
1992 Akbari HM, Kramer HK, Whitaker-Azmitia PM, Spear LP, Azmitia EC. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Research. 572: 57-63. PMID 1535274 DOI: 10.1016/0006-8993(92)90450-N  0.347
1990 Whitaker-Azmitia PM, Quartermain D, Shemer AV. Prenatal treatment with a selective D1 receptor agonist (SKF 38393) alters adult [3H]paroxetine binding and dopamine and serotonin behavioral sensitivity Developmental Brain Research. 57: 181-185. PMID 2150012 DOI: 10.1016/0165-3806(90)90044-Y  0.406
1990 Azmitia EC, Murphy RB, Whitaker-Azmitia PM. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release. Brain Research. 510: 97-103. PMID 1969761 DOI: 10.1016/0006-8993(90)90732-Q  0.328
1989 Whitaker-Azmitia PM, Azmitia EC. Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Research. 497: 80-5. PMID 2790458 DOI: 10.1016/0006-8993(89)90972-4  0.358
1989 Molino LJ, Shemer A, Whitaker-Azmitia PM. SKF 38393: vacillatory behavior in immature rats European Journal of Pharmacology. 161: 223-225. PMID 2566489 DOI: 10.1016/0014-2999(89)90848-0  0.329
1987 Azmitia EC, Whitaker-Azmitia PM. Target cell stimulation of dissociated serotonergic neurons in culture. Neuroscience. 20: 47-63. PMID 3561768 DOI: 10.1016/0306-4522(87)90005-4  0.378
1987 Whitaker-Azmitia PM, Ramirez A, Noreika L, Gannon PJ, Azmitia EC. Onset and duration of astrocytic response to cells transplanted into the adult mammalian brain. Annals of the New York Academy of Sciences. 495: 10-23. PMID 3484344 DOI: 10.1111/J.1749-6632.1987.Tb23662.X  0.31
1987 Whitaker-Azmitia PM, Lauder JM, Shemmer A, Azmitia EC. Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: further evidence for functional fetal serotonin receptors. Brain Research. 430: 285-9. PMID 2955853 DOI: 10.1016/0165-3806(87)90161-1  0.358
1986 Whitaker-Azmitia PM, Azmitia EC. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neuroscience Letters. 67: 307-12. PMID 3461314 DOI: 10.1016/0304-3940(86)90327-7  0.304
1986 Whitaker-Azmitia PM, Azmitia EC. [3H]5-hydroxytryptamine binding to brain astroglial cells: differences between intact and homogenized preparations and mature and immature cultures. Journal of Neurochemistry. 46: 1186-9. PMID 3005509 DOI: 10.1111/J.1471-4159.1986.Tb00636.X  0.327
Show low-probability matches.